Panacea Biotec to set up anti-cancer facility for Rs 50 crore

Panacea Biotec, India’s third largest biotechnology company will set up an anti-cancer facility at Baddi with a total cost of Rs 50 crore, this anti-cancer facility will be operational by end of this year. Its capacity is expected to be around 1.2 million vials annually.

Recently, Panacea Biotec had launched book 'PREVENT - Diabetes & Complications in India: Perspective and Treatment Options'. PREVENT, 1st time in India, is a book that attempts to address management guidelines of diabetes and complications based on Indian perspective.

Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.